Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

Fractyl Health plans to slim down by 17% of its workforce as it focus on weight maintenance for those coming off of GLP-1 drugs.

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...